NO20060122L - 4-(metyl sulfonyl amino) fenyl analoger som vanilloidantagonist som oppviser utmerket analgesisk aktivitet og farmasoytiske sammensetninger innbefattende samme - Google Patents
4-(metyl sulfonyl amino) fenyl analoger som vanilloidantagonist som oppviser utmerket analgesisk aktivitet og farmasoytiske sammensetninger innbefattende sammeInfo
- Publication number
- NO20060122L NO20060122L NO20060122A NO20060122A NO20060122L NO 20060122 L NO20060122 L NO 20060122L NO 20060122 A NO20060122 A NO 20060122A NO 20060122 A NO20060122 A NO 20060122A NO 20060122 L NO20060122 L NO 20060122L
- Authority
- NO
- Norway
- Prior art keywords
- pain
- pharmaceutical compositions
- same
- compositions including
- exhibiting excellent
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/01—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms
- C07C311/02—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
- C07C311/08—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton having the nitrogen atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/18—Sulfonamides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/14—Antitussive agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/10—Drugs for disorders of the urinary system of the bladder
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C303/00—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides
- C07C303/36—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides of amides of sulfonic acids
- C07C303/38—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides of amides of sulfonic acids by reaction of ammonia or amines with sulfonic acids, or with esters, anhydrides, or halides thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C303/00—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides
- C07C303/42—Separation; Purification; Stabilisation; Use of additives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C335/00—Thioureas, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
- C07C335/04—Derivatives of thiourea
- C07C335/06—Derivatives of thiourea having nitrogen atoms of thiourea groups bound to acyclic carbon atoms
- C07C335/10—Derivatives of thiourea having nitrogen atoms of thiourea groups bound to acyclic carbon atoms of an unsaturated carbon skeleton
- C07C335/12—Derivatives of thiourea having nitrogen atoms of thiourea groups bound to acyclic carbon atoms of an unsaturated carbon skeleton the carbon skeleton containing six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C335/00—Thioureas, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
- C07C335/04—Derivatives of thiourea
- C07C335/14—Derivatives of thiourea having nitrogen atoms of thiourea groups bound to carbon atoms of rings other than six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/14—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D295/155—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/02—Systems containing only non-condensed rings with a three-membered ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2602/00—Systems containing two condensed rings
- C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
- C07C2602/04—One of the condensed rings being a six-membered aromatic ring
- C07C2602/10—One of the condensed rings being a six-membered aromatic ring the other ring being six-membered, e.g. tetraline
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2603/00—Systems containing at least three condensed rings
- C07C2603/02—Ortho- or ortho- and peri-condensed systems
- C07C2603/04—Ortho- or ortho- and peri-condensed systems containing three rings
- C07C2603/30—Ortho- or ortho- and peri-condensed systems containing three rings containing seven-membered rings
- C07C2603/32—Dibenzocycloheptenes; Hydrogenated dibenzocycloheptenes
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pulmonology (AREA)
- Rheumatology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Pain & Pain Management (AREA)
- Neurology (AREA)
- Urology & Nephrology (AREA)
- Heart & Thoracic Surgery (AREA)
- Dermatology (AREA)
- Cardiology (AREA)
- Immunology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Epidemiology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Foreliggende oppfinnelse vedrører nye 4-(metylsulfonylamino) fenyl-analoger som en potent vanilloidreseptor-antagonist og farmasøytiske blandinger inneholde samme. Oppfinnelsens forbindelse kan være anvendelig for smertelindring for å forhindre, lindre eller behandle smertelidelser innbefattende smerte, akutt smerte, kronisk smerte, neuropatisk smerte, postoperativ smerte, migrene, arthralgi, neuropatier, nerveskade, diabetisk neuropati, neurodegenerering, neurotiske hudlidelser, slag, urinblære hypersensitivitet, irritabel tarmsyndrom, en respirasjonshdelse så som astma eller kronisk obstruktiv åndedrettslidelse, irritasjon av hud, øye eller slimhinne, ferverscens, duodenalt magesår, inflammatorisk tarmlidelse, inflammatorisk lidelse og akutt urininkontinens.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR20030044552 | 2003-07-02 | ||
PCT/KR2004/001641 WO2005003084A1 (en) | 2003-07-02 | 2004-07-02 | 4-(methyl sulfonyl amino) phenyl analogues as vanilloid antagonist showing excellent analgesic activity and the pharmaceutical compositions comprising the same |
Publications (2)
Publication Number | Publication Date |
---|---|
NO20060122L true NO20060122L (no) | 2006-01-09 |
NO332602B1 NO332602B1 (no) | 2012-11-12 |
Family
ID=36141774
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20060122A NO332602B1 (no) | 2003-07-02 | 2006-01-09 | 4-(metyl sulfonyl amino)fenyl analoger som vanilloidantagonist som oppviser utmerket analgesisk aktivitet og farmasoytiske sammensetninger innbefattende samme |
Country Status (16)
Country | Link |
---|---|
US (1) | US8642657B2 (no) |
EP (1) | EP1658265A4 (no) |
JP (1) | JP4850702B2 (no) |
KR (1) | KR100707123B1 (no) |
CN (1) | CN100537528C (no) |
AU (1) | AU2004253808B2 (no) |
BR (1) | BRPI0412229A (no) |
CA (1) | CA2533547C (no) |
EC (1) | ECSP066321A (no) |
IL (1) | IL172671A (no) |
IS (1) | IS8216A (no) |
NO (1) | NO332602B1 (no) |
NZ (1) | NZ544943A (no) |
RU (1) | RU2362768C2 (no) |
WO (1) | WO2005003084A1 (no) |
ZA (1) | ZA200600895B (no) |
Families Citing this family (41)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE602005009017D1 (de) * | 2004-11-10 | 2008-09-25 | Pfizer | Substituierte n-sulfonylaminobenzyl-2-phenoxyacetamidverbindungen |
CN101087771A (zh) | 2004-11-10 | 2007-12-12 | 辉瑞大药厂 | 经取代n-磺酰基氨基苄基-2-苯氧基乙酰胺化合物 |
JP4906839B2 (ja) | 2005-03-10 | 2012-03-28 | ファイザー株式会社 | 置換n−スルホニルアミノフェニルエチル−2−フェノキシアセトアミド化合物 |
WO2006098554A1 (en) * | 2005-03-16 | 2006-09-21 | Amorepacific Corporation | Novel compounds, isomer thereof or pharmaceutically acceptable salts thereof as vanilloid receptor antagonist; and a pharmaceutical composition containing the same |
CN101160285A (zh) | 2005-03-17 | 2008-04-09 | 辉瑞大药厂 | 适用于治疗疼痛的n-(n-磺酰氨基甲基)环丙烷甲酰胺衍生物 |
MX2007011466A (es) * | 2005-03-19 | 2008-01-16 | Amorepacific Corp | Compuestos novedosos, isomeros de los mismos, o sales farmaceuticamente aceptables de los mismos como antagonistas de receptor de vaniloides, y composiciones farmaceuticas que contienen los mismos. |
DE102005023943A1 (de) | 2005-05-20 | 2006-11-23 | Grünenthal GmbH | Pentafluorsulfanyl-substituierte Verbindung und deren Verwendung zur Herstellung von Arzneimitteln |
DE102005050408A1 (de) * | 2005-10-19 | 2007-04-26 | Grünenthal GmbH | Neue Vanilloidrezeptor-Liganden und ihre Verwendung zur Herstellung von Arzneimitteln |
PL1940821T3 (pl) * | 2005-10-19 | 2013-08-30 | Gruenenthal Gmbh | Nowe ligandy receptora waniloidowego i ich zastosowanie do wytwarzania leków |
JP2009536657A (ja) * | 2006-05-10 | 2009-10-15 | レノビス, インコーポレイテッド | イオンチャンネルリガンドとしてのアミド誘導体およびそれを用いる医薬組成物および方法 |
JP5161873B2 (ja) * | 2006-05-18 | 2013-03-13 | ドムペ・ファ.ル.マ・ソチエタ・ペル・アツィオーニ | (2r)−2−[(4−スルホニル)アミノフェニル]プロパンアミド類と、それらを含有する医薬組成物 |
EP1862454A1 (en) * | 2006-06-02 | 2007-12-05 | Amorepacific Corporation | Novel compounds, isomer thereof or pharmaceutically acceptable salts thereof as vanilloid receptor antagonist; and a pharmaceutical composition containing the same |
US8134004B2 (en) * | 2006-07-11 | 2012-03-13 | Pfizer Inc. | Substituted N-bicyclicalkyl bicycliccarboxyamide compounds |
CA2658925C (en) | 2006-07-27 | 2015-07-14 | Amorepacific Corporation | Novel sulfonylamino acrylamide derivatives, isomer thereof,or pharmaceutically acceptable salts thereof as vanilloid receptor antagonist; and pharmaceutical compositions containing the same |
CA2663408C (en) | 2006-09-15 | 2011-11-01 | Pfizer Inc. | Substituted pyridylmethyl bicyclocarboxyamide compounds |
DE102007018150A1 (de) * | 2007-04-16 | 2008-10-23 | Grünenthal GmbH | VR1-Rezeptor-Liganden und µ-Opioid-Rezeptor-Liganden zur Behandlung von Schmerz |
EP2222631B1 (en) | 2006-10-23 | 2011-08-17 | Pfizer Inc. | Substituted phenylmethyl bicyclocarboxyamide compounds |
WO2008059370A2 (en) | 2006-11-17 | 2008-05-22 | Pfizer Japan Inc. | Substituted bicyclocarboxyamide compounds |
WO2008103769A1 (en) * | 2007-02-20 | 2008-08-28 | Haiyun Tang | High dynamic range transceiver for cognitive radio |
WO2008121859A1 (en) * | 2007-03-30 | 2008-10-09 | Xenon Pharmaceuticals Inc. | Methods of using tricyclic compounds in treating sodium channel-mediated diseases or conditions |
DE102007017884A1 (de) | 2007-04-13 | 2008-10-16 | Grünethal GmbH | Neue Vanilloid-Rezeptor Liganden und ihre Verwendung zur Herstellung von Arzneimitteln |
WO2008125295A2 (de) * | 2007-04-13 | 2008-10-23 | Grünenthal GmbH | Neue vanilloid-rezeptor liganden und ihre verwendung zur herstellung von arzneimitteln |
DE102007018149A1 (de) | 2007-04-16 | 2008-10-23 | Grünenthal GmbH | Neue Vanilloid-Rezeptor Liganden und ihre Verwendung zur Herstellung von Arzneimitteln |
DE102007018151A1 (de) | 2007-04-16 | 2008-10-23 | Günenthal GmbH | Neue Vanilloid-Rezeptor Liganden und ihre Verwendung zur Herstellung von Arzneimitteln |
EP1992228A1 (en) * | 2007-05-14 | 2008-11-19 | Bayer CropScience AG | Insecticidal substituted thiourea derivatives |
WO2009054506A1 (ja) * | 2007-10-25 | 2009-04-30 | Toray Industries, Inc. | 膜ろ過予測方法、予測装置、及び膜ろ過予測プログラム |
WO2009064449A1 (en) * | 2007-11-13 | 2009-05-22 | Renovis, Inc. | Amide derivatives as ion-channel ligands and pharmaceutical compositions and methods of using the same |
CN101925575B (zh) * | 2008-01-28 | 2014-06-18 | 株式会社爱茉莉太平洋 | 作为香草酸受体拮抗剂的化合物、其异构体或其药物学可接受的盐、及包含这些化合物的药物组合物 |
EP2307394B1 (en) * | 2008-07-02 | 2012-09-26 | Amorepacific Corporation | Sulphonamides as vanilloid receptor antagonist |
JP5937353B2 (ja) * | 2008-08-19 | 2016-06-22 | ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプJanssen Pharmaceutica Naamloze Vennootschap | 冷感−メントール受容体拮抗剤 |
KR101367057B1 (ko) | 2009-03-17 | 2014-02-25 | (주)아모레퍼시픽 | 피부 자극 완화용 조성물 |
WO2010056044A2 (ko) * | 2008-11-11 | 2010-05-20 | (주)아모레퍼시픽 | 바닐로이드 수용체 길항제로 작용하는 신규 화합물, 이의 이성질체 또는 이의 약제학적으로 허용 가능한 염 및 이를 포함하는 약학 조성물 |
EP2316820A1 (en) * | 2009-10-28 | 2011-05-04 | Dompe S.p.A. | 2-aryl-propionamide derivatives useful as bradykinin receptor antagonists and pharmaceutical compositions containing them |
CN105820069A (zh) * | 2015-01-05 | 2016-08-03 | 齐鲁工业大学 | 一种n-{4-[3-(3-溴-苯基)-脲基甲基]-2,5-二丁氧基-苯基}-甲磺酰胺新化合物、制备方法及用途 |
CN105820073A (zh) * | 2015-01-05 | 2016-08-03 | 齐鲁工业大学 | 一种n-{[2,5-二乙氧基-4-[3-(3-甲氧基-苯基)-脲基甲基]-苯基}-甲磺酰胺新化合物、制备方法及用途 |
CN105820076A (zh) * | 2015-01-05 | 2016-08-03 | 齐鲁工业大学 | 一种n-[2,5-二乙氧基-4-(3-对-甲苯基-脲基甲基)-苯基]-甲磺酰胺新化合物、制备方法及用途 |
CN105820088A (zh) * | 2015-01-05 | 2016-08-03 | 齐鲁工业大学 | 一种n-(4-溴-苯基)-5-[3-(2,5-二乙氧基-4-甲磺酰基-苄基)-脲基]-2-乙氧基苯甲酰胺新化合物、制备方法及用途 |
CN105820087A (zh) * | 2015-01-05 | 2016-08-03 | 齐鲁工业大学 | 一种5-[3-(2,5-二乙氧基-4-甲磺酰基-苄基)-脲基]-2-乙氧基-n-对甲苯基-苯甲酰胺新化合物、制备方法及用途 |
CN106344552B (zh) * | 2015-07-15 | 2021-04-30 | 齐鲁工业大学 | 新型磺酰胺类化合物、制备方法及其作为蛋白酪氨酸磷酸酯酶1b抑制剂的用途 |
KR20220077140A (ko) * | 2019-10-02 | 2022-06-08 | 도메인 테라퓨틱스 | 프로스타글란딘 e2(pge2) ep4 수용체 길항제 |
DE102022104759A1 (de) | 2022-02-28 | 2023-08-31 | SCi Kontor GmbH | Co-Kristall-Screening Verfahren, insbesondere zur Herstellung von Co-Kristallen |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
MXPA01008403A (es) * | 1999-02-22 | 2003-06-06 | Pacific Corp | Analogos vainillinoides que contienen farmacoforos resiniferatoxinicos como potentes agonistas del receptor para vainillinoides y analgesicos, composiciones y usos de estos. |
WO2002016318A1 (en) * | 2000-08-21 | 2002-02-28 | Pacific Corporation | Novel thiourea derivatives and the pharmaceutical compositions containing the same |
ATE328868T1 (de) * | 2000-08-21 | 2006-06-15 | Pacific Corp | Neue (thio)harnstoffverbindungen und arzneimittelkompositionen, die diese enthalten |
GB0110901D0 (en) * | 2001-05-02 | 2001-06-27 | Smithkline Beecham Plc | Novel Compounds |
-
2004
- 2004-06-22 KR KR1020040046508A patent/KR100707123B1/ko not_active IP Right Cessation
- 2004-07-02 CN CNB2004800245997A patent/CN100537528C/zh not_active Expired - Fee Related
- 2004-07-02 JP JP2006518539A patent/JP4850702B2/ja not_active Expired - Fee Related
- 2004-07-02 RU RU2006102868/04A patent/RU2362768C2/ru not_active IP Right Cessation
- 2004-07-02 NZ NZ544943A patent/NZ544943A/en not_active IP Right Cessation
- 2004-07-02 BR BRPI0412229-1A patent/BRPI0412229A/pt not_active IP Right Cessation
- 2004-07-02 AU AU2004253808A patent/AU2004253808B2/en not_active Ceased
- 2004-07-02 US US10/562,698 patent/US8642657B2/en not_active Expired - Fee Related
- 2004-07-02 EP EP04748386A patent/EP1658265A4/en not_active Withdrawn
- 2004-07-02 IL IL172671A patent/IL172671A/en not_active IP Right Cessation
- 2004-07-02 WO PCT/KR2004/001641 patent/WO2005003084A1/en active Application Filing
- 2004-07-02 ZA ZA200600895A patent/ZA200600895B/xx unknown
- 2004-07-02 CA CA2533547A patent/CA2533547C/en not_active Expired - Fee Related
-
2005
- 2005-12-30 IS IS8216A patent/IS8216A/is unknown
-
2006
- 2006-01-09 NO NO20060122A patent/NO332602B1/no not_active IP Right Cessation
- 2006-01-26 EC EC2006006321A patent/ECSP066321A/es unknown
Also Published As
Publication number | Publication date |
---|---|
KR100707123B1 (ko) | 2007-04-16 |
CA2533547C (en) | 2013-09-10 |
KR20050004006A (ko) | 2005-01-12 |
IS8216A (is) | 2005-12-30 |
AU2004253808B2 (en) | 2011-02-03 |
US8642657B2 (en) | 2014-02-04 |
JP2007521288A (ja) | 2007-08-02 |
BRPI0412229A (pt) | 2006-08-22 |
IL172671A0 (en) | 2006-04-10 |
WO2005003084A1 (en) | 2005-01-13 |
CN1852891A (zh) | 2006-10-25 |
EP1658265A1 (en) | 2006-05-24 |
NZ544943A (en) | 2009-07-31 |
IL172671A (en) | 2013-08-29 |
JP4850702B2 (ja) | 2012-01-11 |
EP1658265A4 (en) | 2006-11-29 |
ECSP066321A (es) | 2006-07-28 |
RU2006102868A (ru) | 2007-08-10 |
AU2004253808A1 (en) | 2005-01-13 |
US20060258884A1 (en) | 2006-11-16 |
CA2533547A1 (en) | 2005-01-13 |
NO332602B1 (no) | 2012-11-12 |
ZA200600895B (en) | 2009-07-29 |
CN100537528C (zh) | 2009-09-09 |
RU2362768C2 (ru) | 2009-07-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20060122L (no) | 4-(metyl sulfonyl amino) fenyl analoger som vanilloidantagonist som oppviser utmerket analgesisk aktivitet og farmasoytiske sammensetninger innbefattende samme | |
EP1311478A4 (en) | NEW THIO-URBAN COMPOUNDS AND MEDICINAL COMPOSITIONS THAT CONTAIN THEM | |
RU2500673C2 (ru) | Гетероциклические ингибиторы мек и способы их применения | |
ATE445609T1 (de) | Substituierte thiophenderivate als glucagonrezeptorantagonisten, herstellung und therapeutische anwendungen | |
NO20084318L (no) | Inhibitorer av II-beta-hydroksystereoid dehydrogenase I | |
NO20084403L (no) | Cykloheksylpyrazol-lactamderivater som inhibitorer av II-beta-hydroksysteroid dehydrogenase I | |
RU2427573C2 (ru) | Новые производные бензимидазола в качестве ингибиторов ваниллоидного рецептора 1 (vr1) | |
TW200720226A (en) | Fluorinated derivatives of 4-(2-amino-1-hydroxiethyl)phenol as agonists of the β2 adrenergic receptor | |
ATE454372T1 (de) | Am histamin-h3-rezeptor wirksame mittel, herstellung und therapeutische anwendungen | |
MX2010001236A (es) | Derivados de 5-fenil-isoxazol-3-carboxamida como moduladores del receptor de potencial transitorio v1 (trpv1). | |
EA200870474A1 (ru) | Ингибиторы 11-бета-гидроксистероид дегидрогеназы 1 | |
EA200870475A1 (ru) | Ингибиторы 11-бета-гидроксистероид-дегидрогеназы типа 1 | |
DE602006012725D1 (de) | Glucagonrezeptorantagonisten, deren herstellung und therapeutische verwendung | |
WO2008097428A3 (en) | Compounds and compositions as modulators of gpr119 activity | |
NO20091620L (no) | Boronsyre og estere som inhibitorer av fettsyreamidhydrolaser | |
MA28706B1 (fr) | Antagoniste des recepteurs du glucagon, preparation et utilisations therapeutiques | |
DE602005020655D1 (de) | Carboxamid-spirolactam-cgrp-rezeptor-antagonisten | |
NO20082000L (no) | Pyrimidinamidforbindelser som PGDS-inhibitorer | |
SE0403006D0 (sv) | New compounds | |
BRPI0507120A (pt) | compostos, processo para a manufatura dos mesmos, composições farmacêuticas que os compreendem, método para o tratamento e/ou profilaxia de enfermidades que estão associadas com a modulação de receptores de cb1 e sua utilização | |
WO2007079163A3 (en) | Prokineticin 1 receptor antagonists | |
WO2007120270A3 (en) | Glucagon receptor antagonists, preparation and therapeutic uses | |
WO2009069032A3 (en) | Novel glucocorticoid receptor agonists | |
DE602006015509D1 (de) | Glucagonrezeptorantagonisten, deren herstellung und therapeutische verwendung | |
WO2006044425A3 (en) | Ophthalmic compositions for treating ocular hypertension |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM1K | Lapsed by not paying the annual fees |